| 摘要 |
An optimized direct compression tablet formulation comprises in parts by weight from about 10% to about 45% of 2-butyl-4-chloro-1[(2'(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]-5-(hydro xymethyl)-imidazole, from about 20% to about 40% microcrystalline cellulose, from about 10% to about 30% lactose, from about 0.5% to about 0.9% magnesium stearate, and from about 5% to about 35% pregel starch. |
